Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Mais filtros

Medicinas Complementares
Tipo de documento
Intervalo de ano de publicação
1.
Rev. Bras. Saúde Mater. Infant. (Online) ; 22(2): 199-211, Apr.-June 2022. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1387185

RESUMO

Abstract Objectives: to assess the effects of vitamin D supplementation during pregnancy on the outcomes of vitamin D concentration in newborns, length at birth, overall health (Apgar), birth weight and maternal vitamin D concentration after childbirth. Methods: this research was conducted in the electronic databases of MEDLINE, LILACS, EMBASE and Cochrane Library until December 2020, using the terms "vitamin D", "pregnancy", "vitamin D deficiency", "infant", "newborn" and their synonyms. Randomized controlled trials were searched by evaluating the effects of maternal vitamin D supplementation in neonates. The data was analyzed on RevMan 5.4 software and the quality of evidence on GRADE. Results: the newborn's overall health condition was presented as Apgar, with a mean difference (MD) of 0.15 (CI95%=0.06-0.25; p=0.002; I2=0%, two studies, 648 participants, moderate quality evidence) at the first minute and 0.11 (CI95%=0.04-0.17; p=0.001; I2=0%, two studies, 648 participants, moderate quality evidence) at the fifth minute. Significant effects were also presented at the length at birth considering any supplemented dose (MD=0.19; CI95%=0.08-0.30; p=0.0010; I2=0%, 1452 participants, low quality evidence) and birth weight in doses higher than 4000IU/day (MD=257.05 (CI95%=137.81-376.29; p<0.0001; I2=14%, 176 participants, moderate quality evidence). Conclusion: vitamin D supplementation during pregnancy improves serum 25 (OH) D concentration and suggests positive effects on overall health condition, length at birth and birth weight. PROSPERO CRD42017073292.


Resumo Objetivos: avaliar os efeitos da suplementação materna de vitamina D durante a gravidez nos desfechos concentração de vitamina D no recém-nascido, comprimento ao nascer, estado geral de saúde (Apgar), peso ao nascer e concentração de vitamina D materna após o nascimento. Métodos: a pesquisa foi conduzida nas bases de dados eletrônicas MEDLINE, LILACS, EMBASE e Cochrane Library até dezembro de 2020, utilizando os termos "vitamin D", "pregnancy", "vitamin D deficiency", "infant", "newborn" e seus sinônimos. Pesquisou-se por ensaios clínicos randomizados avaliando os efeitos da suplementação materna de vitamina D no neonato. Os dados foram analisados pelo software RevMan 5.4 e a avaliação da qualidade das evidências pelo GRADE. Resultados: o estado geral de saúde do recém-nascido foi apresentado como Apgar, com uma diferença de média (DM) de 0,15 (IC95%=0,06-0,25; p=0,002; I2=0%, dois estudos, 648 participantes, evidência de qualidade moderada) para o teste no primeiro minuto e 0,11 (IC95%=0,04-0,17; p=0,001; I2=0%, dois estudos, 648 participantes, evidência de qualidade moderada) para quinto minuto. Efeitos significativos também foram apresentados para o comprimento ao nascer em qualquer dose suplementada (DM=0,19 (IC95%=0,08-0,30; p=0,0010; I2=0%, 1452 participantes, evidência de baixa qualidade) e peso ao nascer em doses maiores que 4000UI/dia (DM=257,05 (IC95%=137,81-376,29; p<0,0001; I2=14%, 176 participantes, evidência de qualidade moderada). Conclusão: a suplementação de vitamina D durante a gravidez melhora a concentração sérica de 25 (OH)D e sugere apresentar efeitos positivos no estado geral de saúde, comprimento ao nascer e peso ao nascer. PROSPERO CRD42017073292.


Assuntos
Humanos , Feminino , Gravidez , Recém-Nascido , Lactente , Vitamina D/farmacologia , Deficiência de Vitamina D/prevenção & controle , Peso ao Nascer/efeitos dos fármacos , Suplementos Nutricionais , Tamanho Corporal/efeitos dos fármacos , Cefalometria , Gestantes , Nutrição Materna
2.
Sci Rep ; 11(1): 5, 2021 01 06.
Artigo em Inglês | MEDLINE | ID: mdl-33408364

RESUMO

This 9-month randomised, parallel, double-blind, single-centre, placebo-controlled study (PROBE, ISRCTN18030882) assessed the impact of probiotic supplementation on bodyweight. Seventy overweight Bulgarian participants aged 45-65 years with BMI 25-29.9 kg/m2 received a daily dose of the Lab4P probiotic comprising lactobacilli and bifidobacteria (50 billion cfu/day). Participants maintained their normal diet and lifestyle over the duration of the study. The primary outcome was change from baseline in body weight and secondary outcomes included changes in waist circumference, hip circumference and blood pressure. A significant between group decrease in body weight (3.16 kg, 95% CI 3.94, 2.38, p < 0.0001) was detected favouring the probiotic group. Supplementation also resulted in significant between group decreases in waist circumference (2.58 cm, 95% CI 3.23, 1.94, p < 0.0001) and hip circumference (2.66 cm, 95% CI 3.28, 2.05, p < 0.0001) but no changes in blood pressure were observed. These findings support the outcomes of a previous shorter-term Lab4P intervention study in overweight and obese participants (PROMAGEN, ISRCTN12562026). We conclude that Lab4P has consistent weight modulation capability in free-living overweight adults.


Assuntos
Suplementos Nutricionais , Sobrepeso/dietoterapia , Probióticos/uso terapêutico , Redução de Peso/efeitos dos fármacos , Bifidobacterium , Pressão Sanguínea/efeitos dos fármacos , Tamanho Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Bulgária , Método Duplo-Cego , Feminino , Humanos , Lactobacillus , Masculino , Pessoa de Meia-Idade , Circunferência da Cintura/efeitos dos fármacos
3.
J Clin Endocrinol Metab ; 106(3): e1140-e1155, 2021 03 08.
Artigo em Inglês | MEDLINE | ID: mdl-33347567

RESUMO

CONTEXT: The relationship between maternal and infant vitamin D and early childhood growth remains inadequately understood. OBJECTIVE: This work aimed to investigate how maternal and child 25-hydroxyvitamin D (25[OH]D) and vitamin D supplementation affect growth during the first 2 years of life. METHODS: A randomized, double-blinded, single-center intervention study was conducted from pregnancy until offspring age 2 years. Altogether 812 term-born children with complete data were recruited at a maternity hospital. Children received daily vitamin D3 supplementation of 10 µg (group 10) or 30 µg (group 30) from age 2 weeks to 2 years. Anthropometry and growth rate were measured at age 1 and 2 years. RESULTS: Toddlers born to mothers with pregnancy 25(OH)D greater than 125 nmol/L were at 2 years lighter and thinner than the reference group with 25(OH)D of 50 to 74.9 nmol/L (P < .010). Mean 2-year 25(OH)D concentrations were 87 nmol/L in group 10 and 118 nmol/L in group 30 (P < .001). When group 30 was compared with group 10, difference in body size was not statistically significant (P > .053), but group 30 had slower growth in length and head circumference between 6 months and 1 year (P < .047), and more rapid growth in weight and length-adjusted weight between 1 and 2 years (P < .043). Toddlers in the highest quartile of 25(OH)D (> 121 nmol/L) were shorter (mean difference 0.2 SD score [SDS], P = .021), lighter (mean difference 0.4 SDS, P = .001), and thinner (in length-adjusted weight) (mean difference 0.4 SDS, P = .003) compared with the lowest quartile (< 81.2 nmol/L). CONCLUSION: Vitamin D and early childhood growth may have an inverse U-shaped relationship.


Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Colecalciferol/farmacologia , Adulto , Tamanho Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Pré-Escolar , Colecalciferol/administração & dosagem , Colecalciferol/sangue , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Finlândia , Humanos , Lactente , Recém-Nascido , Masculino , Gravidez , Efeitos Tardios da Exposição Pré-Natal/sangue , Vitamina D/análogos & derivados , Vitamina D/sangue , Deficiência de Vitamina D/sangue
4.
J Therm Biol ; 89: 102544, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32364987

RESUMO

In order to investigate the effects of dietary ginger extract (GE) enriched in gingerols on broilers under heat stress (HS) from 21 to 42 days of age, a total of 144 Ross 308 male broilers were randomly allocated to three groups with six replicates of eight broilers per replicate. Broilers in the control group were raised at 22 °C and fed a basal diet, and broilers in the other two groups were raised under cyclic HS (34 °C from 9:00 to 17:00 and at 22 °C for the rest of the time) and fed the basal diet with or without 1000 mg/kg GE. Supplementation of GE improved (P < 0.05) final body weight, average daily gain and feed conversion ratio of broilers under HS, and tended (P < 0.1) to increase breast muscle yield. The alterations of serum total protein, albumin, total cholesterol levels and aspartate aminotransferase activity under HS were reversed (P < 0.05) by GE, which also decreased (P < 0.05) serum triglyceride level and alanine aminotransferase activity. The decreased redness (a* value) and increased drip loss of breast muscle induced by HS were restored (P < 0.05) by GE. Moreover, GE supplementation increased (P < 0.05) total antioxidant capacity and decreased (P < 0.05) malondialdehyde content in liver and breast muscle, and increased (P < 0.05) glutathione peroxidase activity in serum and breast muscle. In conclusion, dietary GE supplementation restored growth performance, serum metabolites and meat quality of broilers under HS possibly by improving antioxidant activity.


Assuntos
Antioxidantes/farmacologia , Tamanho Corporal/efeitos dos fármacos , Catecóis/farmacologia , Galinhas/fisiologia , Álcoois Graxos/farmacologia , Resposta ao Choque Térmico/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Proteínas Sanguíneas/análise , Galinhas/sangue , Galinhas/crescimento & desenvolvimento , Colesterol/sangue , Zingiber officinale/química , Glutationa Peroxidase/sangue , Glutationa Peroxidase/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Malondialdeído/sangue , Malondialdeído/metabolismo , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Produtos Avícolas/normas , Triglicerídeos/sangue
5.
PLoS One ; 15(5): e0232197, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32469870

RESUMO

Obtaining a nutrient-rich diet during pregnancy is a challenge for pregnant women living in low-income countries. This randomized, controlled trial was designed to determine if a freshly prepared food supplement from local animal-source foods and dark-green leafy vegetables given prior to and/or during pregnancy improved birth outcomes in rural Vietnamese women. Primiparous women, 18 to 30 years of age, who participated in the study were assigned to one of three groups: PC-T women received the supplement from pre-conception to term, MG-T women received the supplement from mid-gestation to term, and the RPC women received routine prenatal care. Supplement intake was observed and quantified. Infant anthropometry was measured at birth and/or within seven days of delivery. The effect of the intervention on maternal and birth outcomes was determined using linear regression modeling. Of the 460 women enrolled in the study, 317 women completed the study. Those not completing the study had either moved from the area, did not conceive within 12 months of study enrollment, or miscarried. The food-based supplement increased protein, iron, zinc, folate, vitamin A and B12 intakes in the PC-T and the MG-T groups. However, it failed to alter infant anthropometric measurements at birth. In the entire cohort, maternal gestational weight gain was greater in women with a low pre-pregnancy BMI (<18.5) and in women with a higher educational attainment. Working as a farmer reduced gestational weight gain but it did not affect birth weight or length. In summary, a nutrient-rich, food-based supplement given to rural Vietnamese women from pre-conception to term or mid-gestation to term did not affect maternal or infant outcomes. The low weight gains, possibly due to demanding farm work done throughout the reproductive cycle, may have obviated any effects of the low energy, nutrient-rich food supplement on birth outcomes. Trial registration : Registered Clinical Trials.gov: NCT01235767.


Assuntos
Suplementos Nutricionais/análise , Mães/estatística & dados numéricos , Nutrientes/análise , Resultado da Gravidez , População Rural/estatística & dados numéricos , Peso ao Nascer/efeitos dos fármacos , Tamanho Corporal/efeitos dos fármacos , Estudos de Coortes , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Gravidez , Nascimento Prematuro/epidemiologia , Vietnã , Adulto Jovem
6.
Artif Cells Nanomed Biotechnol ; 47(1): 2930-2939, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31317780

RESUMO

The prevalence of obesity is increasing at an alarming rate worldwide with about 30% of the world population classified as obese. Obese body structure results when energy intake exceeds energy expenditure in an individual. Increase in the consumption of high-energy eatables, in the context of portion and energy provided, has resulted in obese populations which is becoming the leading cause of metabolic disorders related to morbidity. The obesity-related comorbidity is an enormous liability on health services and will affect measures taken in tackling the increasing obesity rate. Prevention of an obese phenotype is the most suitable long-term strategy. Another approach towards the treatment of obesity is weight management through phytotherapeutics. In this study, we explored the anti-obesity effects of Cinnamon (Cinnamomum zeylanicum) in adult male zebrafish. Through BMI measurements, blood glucose level analyses, serum triglyceride analyses, Oil Red O staining as well as quantitative Real Time-PCR, the ability of cinnamon to reduce metabolic disorders associated with obesity is investigated for the first time in a zebrafish model. Our studies indicate that cinnamon ameliorates the genotypic and phonotypic characteristics associated with obesity through lowering of BMI, blood glucose, triglyceride levels, lipid levels in the liver and through gene modulation.


Assuntos
Adiposidade/efeitos dos fármacos , Glicemia/metabolismo , Cinnamomum zeylanicum/química , Dieta/efeitos adversos , Regulação da Expressão Gênica/efeitos dos fármacos , Obesidade/metabolismo , Obesidade/patologia , Animais , Índice de Massa Corporal , Tamanho Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Modelos Animais de Doenças , Fígado/efeitos dos fármacos , Fígado/patologia , Obesidade/etiologia , Obesidade/genética , Triglicerídeos/sangue , Peixe-Zebra
7.
BMC Complement Altern Med ; 19(1): 164, 2019 Jul 08.
Artigo em Inglês | MEDLINE | ID: mdl-31286949

RESUMO

BACKGROUND: Caesalpinia mimosoides, a vegetable consumed in Thailand, has been reported to exhibit in vitro antioxidant properties. The in vivo antioxidant and anti-aging activities have not been investigated. The aim of this research was to study the antioxidant activity of C. mimosoides extracts in Caenorhabditis elegans, a widely used model organism in this context. METHODS: C. elegans were treated with C. mimosoides extracts in a various concentrations. To investigate the protective effects of the extract against oxidative stress, wild-type N2 were used to determine survival rate under oxidative stress and intracellular ROS. To study underlying mechanisms, the mutant strains with GFP reporter gene including TJ356, CF1553, EU1 and LD4 were used to study DAF-16, SOD-3, SKN-1 and GST-4 gene, respectively. Lifespan and aging pigment of the worms were also investigated. RESULTS: A leaf extract of C. mimosoides improved resistance to oxidative stress and reduced intracellular ROS accumulation in nematodes. The antioxidant effects were mediated through the DAF-16/FOXO pathway and SOD-3 expression, whereas the expression of SKN-1 and GST-4 were not altered. The extract also prolonged lifespan and decreased aging pigments, while the body length and brood size of the worms were not affected by the extract, indicating low toxicity and excluding dietary restriction. CONCLUSIONS: The results of this study establish the antioxidant activity of C. mimosoides extract in vivo and suggest its potential as a dietary supplement and alternative medicine to defend against oxidative stress and aging, which should be investigated in intervention studies.


Assuntos
Antioxidantes/farmacologia , Caenorhabditis elegans/efeitos dos fármacos , Caesalpinia/química , Longevidade/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Tamanho Corporal/efeitos dos fármacos , Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/fisiologia , Proteínas de Caenorhabditis elegans/metabolismo , Flavonoides/análise , Sequestradores de Radicais Livres/farmacologia , Metanol , Naftoquinonas , Fenóis/análise , Folhas de Planta/química , Espécies Reativas de Oxigênio , Reprodução/efeitos dos fármacos
8.
Nat Prod Res ; 33(11): 1591-1598, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29376418

RESUMO

Mustard oil cake (MOC) is widely used as biofertilizer in the field of agriculture and aquaculture. Channa punctatus was exposed to 0.42 g.L-1 sublethal concentration for 4, 7, 14, 21 and 28 days. Due to such exposure, body growth and histological changes in liver were observed. It was revealed that weight, length and breadth of fish were gradually increased with the days of exposure in compare to control fish, whereas, liver showed an increase in sinusoidal space and lipidosis during early days, followed by a recovery from the stress of MOC on the 28th day.


Assuntos
Aquicultura/métodos , Fertilizantes/toxicidade , Peixes/crescimento & desenvolvimento , Fígado/efeitos dos fármacos , Animais , Tamanho Corporal/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Fígado/patologia , Mostardeira/química , Óleos de Plantas/química , Poluentes Químicos da Água/toxicidade
9.
Clin Nutr ; 37(4): 1340-1347, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-28648475

RESUMO

BACKGROUND: Hypertriglyceridemia is common in HIV-infected patients. Polyunsaturated fatty acids reduce fasting serum triglyceride (TG) levels in HIV-infected patients. It is not known whether docosahexanoic acid (DHA) supplementation can reduce hypertriglyceridemia and modify fat distribution in HIV-infected patients. METHODS: We conducted a randomized, double-blind, placebo-controlled trial with 84 antiretroviral-treated patients who had fasting TG levels from 2.26 to 5.65 mmol/l and were randomized to receive DHA or placebo for 48 weeks. TG levels were assessed at baseline, week 4 and every 12 weeks. Body composition was assessed at baseline and at week 48. Registered under ClinicalTrials.gov Identifier no. NCT02005900. RESULTS: Patients receiving DHA had a 43.9% median decline in fasting TG levels at week 4 (IQR: -31% to -56%), compared with -2.9% (-18.6% to 16.5%) in the placebo group (P < 0.0001). DHA levels and decrease in TG at week 4 in the DHA arm correlated significantly (r = 0.7110, P < 0.0001). The median reduction in TG levels in the DHA arm was -43.7% (-32.4% to -57.5%), and in the placebo arm +2.9% (-21.3% to +30.1%) at week 12. The difference remained statistically significant at week 48 (P = 0.0253). LDL cholesterol levels significantly increased at week 4 by 7.1% (IQR: -4.8% to +35.3%) in the DHA arm but not in the placebo group. No significant changes were observed in HDL cholesterol, insulin, and HOMA-IR during the study. Limb fat significantly increased in both arms, without statistically significant differences between groups (P = 0.3889). DHA was well tolerated; only 3 patients experienced treatment-limiting toxicity. CONCLUSIONS: Supplementation with DHA reduced fasting TG levels in antiretroviral-treated HIV-infected patients with mild hypertriglyceridemia. DHA was well tolerated with minor GI symptoms. Peripheral fat significantly increased in the DHA group but did not increase significantly compared with placebo.


Assuntos
Tecido Adiposo/efeitos dos fármacos , Anti-Inflamatórios/uso terapêutico , Antirretrovirais/uso terapêutico , Ácidos Docosa-Hexaenoicos/uso terapêutico , Infecções por HIV/tratamento farmacológico , Adulto , Anti-Inflamatórios/efeitos adversos , Anti-Inflamatórios/farmacologia , Tamanho Corporal/efeitos dos fármacos , Ácidos Docosa-Hexaenoicos/efeitos adversos , Ácidos Docosa-Hexaenoicos/farmacologia , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Infecções por HIV/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Triglicerídeos/sangue
10.
Am J Clin Nutr ; 106(2): 549-558, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28637773

RESUMO

Background: Early nutritional interventions may modulate health risks in preterm-born infants. Previously, we showed that preterm-born infants fed an isocaloric protein- and mineral-enriched postdischarge formula (PDF) from term age to 6-mo corrected age (CA) gained more lean mass than did those fed term formula (TF). Long-term follow-up of randomized nutritional trials is important to test the hypothesis that short-term positive effects on health are sustainable.Objective: The aim of this follow-up study was to compare body size, body composition, and metabolic health at age 8 y in preterm-born children who were randomly assigned to receive either PDF or TF from term age until 6-mo CA.Design: A total of 79 of 152 children (52%) from the original randomized controlled trial were enrolled for follow-up at age 8 y. Weight, height, and head circumference were measured by using standard methods. Body composition, including fat mass, lean mass, bone mineral content, and bone mineral density, was determined by dual-energy X-ray absorptiometry. Blood pressure was measured in the supine position by using an automatic device. Metabolic variables, including glucose, insulin, insulin-like growth factor I, triglycerides, cholesterol, cortisol, and leptin, were measured after an overnight fast. Nutritional habits at age 8 y were assessed by using a 3-d nutritional diary.Results: At age 8 y, no differences were found in body size, body composition, bone variables, and metabolic health variables when comparing children fed PDF with those fed TF. Adjustment for known and possible confounders did not change these results.Conclusions: In this follow-up study in preterm-born children, we showed that the favorable effects of PDF at 6-mo CA either were not maintained or could not be confirmed because of attrition at the age of 8 y. We suggest that future research should focus on nutritional interventions in the pre- and postdischarge period as a continuum rather than as separate entities. This trial was registered at www.trialregister.nl as NTR 2972 (follow-up study [STEP-2 (Study Towards the Effects of Post-discharge Nutrition 2)]) and NTR 55 [original randomized controlled trial (STEP)].


Assuntos
Dieta , Proteínas Alimentares/farmacologia , Alimentos Fortificados , Fórmulas Infantis/química , Recém-Nascido Prematuro/crescimento & desenvolvimento , Minerais/farmacologia , Estado Nutricional/efeitos dos fármacos , Tecido Adiposo/metabolismo , Glicemia/metabolismo , Composição Corporal/efeitos dos fármacos , Compartimentos de Líquidos Corporais/metabolismo , Tamanho Corporal/efeitos dos fármacos , Densidade Óssea , Criança , Feminino , Seguimentos , Hormônios/sangue , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente , Recém-Nascido , Recém-Nascido Prematuro/metabolismo , Lipídeos/sangue , Masculino
11.
BMC Endocr Disord ; 17(1): 1, 2017 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-28183304

RESUMO

BACKGROUND: Obese, type two diabetics are at an increased risk for fracturing their limb bones in comparison to the general population. Phytoestrogens like as the soy isoflavone genistein have been shown to protect against bone loss. In this study, we tested the effects of genistein treatment on femurs of ob/ob mice, a model for obesity and type two diabetes mellitus. METHODS: Twenty six-week-old female mice were divided into obese (ob/ob) control, obese genistein-treated, lean (ob/+) control, and lean genistein-treated groups (n = 5 each). Treatment with genistein consisted of 600 mg genistein/kg diet. Control mice were given standard rodent chow. At the end of a four-week treatment period, bone histomorphometric and three-point bending properties were compared among groups. RESULTS: Obese mice had larger bone areas (B.Ar.; P < 0.05) and total areas (Tt.Ar.; P < 0.05), but similar bone volume (B.Ar./Tt.Ar.; P > 0.05) of the proximal femoral epiphysis in comparison to lean mice. Treatment with genistein decreased Tt.Ar. and femur length, and increased ultimate force required to fracture the femur and the maximum deformation to failure (P < 0.05). CONCLUSIONS: Genistein improves resistance to fracture from bending loads.


Assuntos
Fraturas Ósseas/prevenção & controle , Genisteína/uso terapêutico , Obesidade/patologia , Fitoestrógenos/uso terapêutico , Animais , Fenômenos Biomecânicos , Tamanho Corporal/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Fêmur/efeitos dos fármacos , Fêmur/patologia , Camundongos
12.
PLoS One ; 11(5): e0155958, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27213896

RESUMO

Glycoalkaloids are secondary metabolites commonly found in Solanaceae plants. They have anti-bacterial, anti-fungal and insecticidal activities. In the present study we examine the effects of potato and tomato leaf extracts and their main components, the glycoalkaloids α-solanine, α-chaconine and α-tomatine, on development and reproduction of Drosophila melanogaster wild-type flies at different stages. Parental generation was exposed to five different concentrations of tested substances. The effects were examined also on the next, non-exposed generation. In the first (exposed) generation, addition of each extract reduced the number of organisms reaching the pupal and imaginal stages. Parent insects exposed to extracts and metabolites individually applied showed faster development. However, the effect was weaker in case of single metabolites than in case of exposure to extracts. An increase of developmental rate was also observed in the next, non-exposed generation. The imagoes of both generations exposed to extracts and pure metabolites showed some anomalies in body size and malformations, such as deformed wings and abdomens, smaller black abdominal zone. Our results further support the current idea that Solanaceae can be an impressive source of molecules, which could efficaciously be used in crop protection, as natural extract or in formulation of single pure metabolites in sustainable agriculture.


Assuntos
Drosophila melanogaster/fisiologia , Extratos Vegetais/farmacologia , Reprodução/efeitos dos fármacos , Solanum lycopersicum/química , Solanum tuberosum/química , Animais , Tamanho Corporal/efeitos dos fármacos , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/crescimento & desenvolvimento , Feminino , Masculino , Controle Biológico de Vetores , Extratos Vegetais/química , Folhas de Planta/química , Solanina/análogos & derivados , Solanina/farmacologia , Tomatina/análogos & derivados , Tomatina/farmacologia
13.
Acta Biochim Pol ; 63(2): 287-95, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27119728

RESUMO

Diosgenin is a steroidal sapogenin present in fenugreek and Dioscorea spp. as glycosides (saponins). Diosgenin has already been reported to inhibit osteoclastogenesis and to stimulate osteogenic activity of osteoblastic cells in vitro, and to exert some antiosteoporotic effects in rats in vivo. The aim of the present study was to investigate the effects of diosgenin administration on the skeletal system of rats with normal estrogen level and with estrogen deficiency induced by bilateral ovariectomy. The experiments were carried out on 3-month-old non-ovariectomized and ovariectomized Wistar rats, divided into control rats and rats receiving diosgenin (50 mg/kg p.o. daily) for 4 weeks. Serum bone turnover markers, bone mass and mineralization, histomorphometric parameters and mechanical properties were studied. Diosgenin improved some investigated parameters in both non-ovariectomized and ovariectomized rats, in which estrogen deficiency induced osteoporotic changes. Diosgenin increased compact bone formation and probably inhibited cancellous bone resorption, which led to improvement of mechanical properties of compact and cancellous bone. In conclusion, this in vivo study demonstrated that diosgenin may be one of sparse compounds increasing bone formation.


Assuntos
Conservadores da Densidade Óssea/farmacologia , Diosgenina/farmacologia , Animais , Tamanho Corporal/efeitos dos fármacos , Densidade Óssea/efeitos dos fármacos , Calcificação Fisiológica/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Feminino , Fraturas Ósseas/prevenção & controle , Osteoporose/tratamento farmacológico , Ratos Wistar
14.
Environ Health Perspect ; 124(3): 373-9, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26115160

RESUMO

BACKGROUND: Methylmercury (MeHg) may affect fetal growth; however, prior research often lacked assessment of mercury speciation, confounders, and interactions. OBJECTIVE: Our objective was to assess the relationship between MeHg and fetal growth as well as the potential for confounding or interaction of this relationship from speciated mercury, fatty acids, selenium, and sex. METHODS: This cross-sectional study includes 271 singletons born in Baltimore, Maryland, 2004-2005. Umbilical cord blood was analyzed for speciated mercury, serum omega-3 highly unsaturated fatty acids (n-3 HUFAs), and selenium. Multivariable linear regression models controlled for gestational age, birth weight, maternal age, parity, prepregnancy body mass index, smoking, hypertension, diabetes, selenium, n-3 HUFAs, and inorganic mercury (IHg). RESULTS: Geometric mean cord blood MeHg was 0.94 µg/L (95% CI: 0.84, 1.07). In adjusted models for ponderal index, ßln(MeHg) = -0.045 (g/cm(3)) × 100 (95% CI: -0.084, -0.005). There was no evidence of a MeHg × sex interaction with ponderal index. Contrastingly, there was evidence of a MeHg × n-3 HUFAs interaction with birth length [among low n-3 HUFAs, ßln(MeHg) = 0.40 cm, 95% CI: -0.02, 0.81; among high n-3 HUFAs, ßln(MeHg) = -0.15, 95% CI: -0.54, 0.25; p-interaction = 0.048] and head circumference [among low n-3 HUFAs, ßln(MeHg) = 0.01 cm, 95% CI: -0.27, 0.29; among high n-3 HUFAs, ßln(MeHg) = -0.37, 95% CI: -0.63, -0.10; p-interaction = 0.042]. The association of MeHg with birth weight and ponderal index was affected by n-3 HUFAs, selenium, and IHg. For birth weight, ßln(MeHg) without these variables was -16.8 g (95% CI: -75.0, 41.3) versus -29.7 (95% CI: -93.9, 34.6) with all covariates. Corresponding values for ponderal index were -0.030 (g/cm(3)) × 100 (95% CI: -0.065, 0.005) and -0.045 (95% CI: -0.084, -0005). CONCLUSION: We observed an association of increased MeHg with decreased ponderal index. There is evidence for interaction between MeHg and n-3 HUFAs; infants with higher MeHg and n-3 HUFAs had lower birth length and head circumference. These results should be verified with additional studies.


Assuntos
Ácidos Graxos Ômega-3/sangue , Sangue Fetal/química , Desenvolvimento Fetal/efeitos dos fármacos , Compostos de Metilmercúrio/sangue , Selênio/sangue , Baltimore , Peso ao Nascer/efeitos dos fármacos , Tamanho Corporal/efeitos dos fármacos , Cefalometria , Estudos Transversais , Feminino , Humanos , Recém-Nascido , Masculino , Gravidez , Fatores Sexuais
15.
PLoS One ; 10(7): e0134612, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26226016

RESUMO

Royal Jelly (RJ) is a product made by honey bee workers and is required for queen differentiation and accompanying changes in queen body size, development time, lifespan and reproductive output relative to workers. Previous studies have reported similar changes in Drosophila melanogaster in response to RJ. Here, we quantified viability, development time, body size, productivity, lifespan and genome wide transcript abundance of D. melanogaster reared on standard culture medium supplemented with increasing concentrations of RJ. We found that lower concentrations of RJ do induce significant differences in body size in both sexes; higher concentrations reduce size, increase mortality, shorten lifespan and reduce productivity. Increased concentrations of RJ also consistently lengthened development time in both sexes. RJ is associated with changes in expression of 1,581 probe sets assessed using Affymetrix Drosophila 2.0 microarrays, which were enriched for genes associated with metabolism and amino acid degradation. The transcriptional changes are consistent with alterations in cellular processes to cope with excess nutrients provided by RJ, including biosynthesis and detoxification, which might contribute to accelerated senescence and reduced lifespan.


Assuntos
Drosophila melanogaster/efeitos dos fármacos , Ácidos Graxos/farmacologia , Expressão Gênica/efeitos dos fármacos , Hormônios de Inseto/farmacologia , Animais , Tamanho Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Drosophila melanogaster/genética , Drosophila melanogaster/crescimento & desenvolvimento , Drosophila melanogaster/fisiologia , Longevidade/efeitos dos fármacos
16.
Environ Toxicol Chem ; 34(8): 1870-80, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26096773

RESUMO

A field study was conducted in Wisconsin (USA) to characterize in ovo mercury (Hg) exposure in common loons (Gavia immer). Total Hg mass fractions ranged from 0.17 µg/g to 1.23 µg/g wet weight in eggs collected from nests on lakes representing a wide range of pH (5.0-8.1) and were modeled as a function of maternal loon Hg exposure and egg laying order. Blood total Hg mass fractions in a sample of loon chicks ranged from 0.84 µg/g to 3.86 µg/g wet weight at hatch. Factors other than mercury exposure that may have persistent consequences on development of chicks from eggs collected on low-pH lakes (i.e., egg selenium, calcium, and fatty acid mass fractions) do not seem to be contributing to reported differences in loon chick quality as a function of lake pH. However, it was observed that adult male loons holding territories on neutral-pH lakes were larger on average than those occupying territories on low-pH lakes. Differences in adult body size of common loons holding territories on neutral-versus low-pH lakes may have genetic implications for differences in lake-source-related quality (i.e., size) in chicks. The tendency for high in ovo Hg exposure and smaller adult male size to co-occur in low-pH lakes complicates the interpretation of the relative contributions of each to resulting chick quality.


Assuntos
Aves/metabolismo , Galinhas/metabolismo , Lagos/química , Mercúrio/análise , Óvulo/química , Animais , Tamanho Corporal/efeitos dos fármacos , Cálcio/análise , Cálcio/sangue , Cromatografia Gasosa , Feminino , Concentração de Íons de Hidrogênio , Masculino , Mercúrio/sangue , Mercúrio/toxicidade , Compostos de Metilmercúrio/análise , Compostos de Metilmercúrio/sangue , Óvulo/metabolismo , Selênio/análise , Selênio/sangue , Espectrofotometria Atômica , Wisconsin
17.
Environ Entomol ; 43(6): 1584-93, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25369112

RESUMO

Mosquitoes are one of the most globally important insect pests and vectors of human pathogens, and their populations may be facilitated or inhibited by anthropogenic environmental change. Invasive plant species are an important management concern and environmental modifier in many ecosystems; these plant invasions have the potential to exacerbate or diminish mosquito populations. The purpose of this study was to assess potential effects of a highly invasive plant, Lonicera maackii, on a common mosquito species Culex pipiens L., which is an important pathogen vector in the United States. Three microcosm assays were conducted to determine the responses of C. pipiens life history attributes of larval survivorship, growth, and pupation when subjected to leachate from two native plant leaves (Platanus occidentalis and Acer saccharum) and both the leaves and flowers of L. maackii. Only C. pipiens larvae exposed to L. maackii leachate pupated and emerged as adults. However, in all three assays there were statistically significant differences in survivorship and body size change among treatments, and in each assay the highest survivorship and maximum larval size was found in the L. maackii leachate treatments, suggesting positive effects on certain life history traits. This study is one of the first to demonstrate the potential facilitative effect of this invasive plant species on an insect vector and suggests that plant invasion could have positive feedbacks into mosquito population dynamics and, ultimately, human disease.


Assuntos
Culex/crescimento & desenvolvimento , Interações Hospedeiro-Parasita/fisiologia , Espécies Introduzidas , Estágios do Ciclo de Vida/fisiologia , Lonicera/parasitologia , Análise de Variância , Animais , Tamanho Corporal/efeitos dos fármacos , Tamanho Corporal/fisiologia , Culex/efeitos dos fármacos , Flores/química , Lonicera/química , Ohio , Extratos Vegetais/farmacologia , Folhas de Planta/química , Dinâmica Populacional
18.
Nutr Res ; 34(10): 856-61, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25277886

RESUMO

High-protein diets exert beneficial effects on appetite, anthropometry, and body composition; however, the effects of protein preloads depend on the amount, type, and time of consumption. Therefore, we hypothesized that long-term supplemental preloads of whey protein concentrate (WPC) and soy protein isolate (SPI) consumed 30 minutes before the largest meal would decrease appetite, calorie intake (CI), and anthropometry and improve body composition in overweight and obese men in free-living conditions. The subjects included 45 men with a body mass index between 25 and 40 kg/m(2) and who were randomly allocated to either the WPC (n = 26) or SPI (n = 19) groups. For 12 weeks, the subjects consumed 65 g WPC or 60 g SPI that was dissolved in 500 mL water 30 minutes before their ad libitum lunch. Appetite, CI, anthropometry, and body composition were assessed before and after the study and biweekly throughout. After 12 weeks, mean changes between the groups were significant for appetite (P = .032), CI (P = .045), anthropometry (body weight [P = .008], body mass index [P = .006], and waist circumference), and body composition (body fat mass and lean muscle [P < .001]). Relative to baseline, within-group mean changes from WPC were significant for appetite, CI, anthropometry, and body composition (P < .001). In the SPI group, mean changes were significant, relative to baseline, for all variables except lean muscle (P = .37). According to this 12-week study, WPC preloads conducted 30 minutes prior to the ad libitum main meal exerted stronger beneficial effects than did SPI preloads on appetite, CI, anthropometry, and body composition of free-living overweight and obese men.


Assuntos
Apetite/efeitos dos fármacos , Composição Corporal/efeitos dos fármacos , Tamanho Corporal/efeitos dos fármacos , Ingestão de Energia/efeitos dos fármacos , Proteínas do Leite/uso terapêutico , Obesidade/dietoterapia , Proteínas de Soja/uso terapêutico , Tecido Adiposo/metabolismo , Adulto , Idoso , Animais , Antropometria , Compartimentos de Líquidos Corporais/metabolismo , Índice de Massa Corporal , Proteínas Alimentares/administração & dosagem , Proteínas Alimentares/farmacologia , Proteínas Alimentares/uso terapêutico , Ingestão de Alimentos , Humanos , Masculino , Refeições , Pessoa de Meia-Idade , Proteínas do Leite/administração & dosagem , Proteínas do Leite/farmacologia , Músculos , Obesidade/metabolismo , Proteínas de Soja/administração & dosagem , Proteínas de Soja/farmacologia , Glycine max/química , Proteínas do Soro do Leite
19.
Exp Gerontol ; 57: 81-95, 2014 09.
Artigo em Inglês | MEDLINE | ID: mdl-24835194

RESUMO

Beta-caryophyllene (BCP) is a natural bicyclic sesquiterpene and is a FDA approved food additive, found as an active ingredient in essential oils of numerous edible plants. It possesses a wide range of biological activities including anti-oxidant, anti-inflammatory, anti-cancerous and local anesthetic actions. We used the well established Caenorhabditis elegans model system to elucidate the stress modulatory and lifespan prolonging action of BCP. The present study for the first time reports the lifespan extension and stress modulation potential of BCP in C. elegans. Upon evaluation, it was found that 50µM dose of BCP increased the lifespan of C. elegans by over 22% (P≤0.0001) and significantly reduced intracellular free radical levels, maintaining cellular redox homeostasis. Moreover, the results suggest that BCP modulates feeding behavior, pharyngeal pumping and body size effectively. Further, this compound also exhibited significant reduction in intestinal lipofuscin levels. In the present investigation, we have predicted possible biological molecular targets for BCP using molecular docking approaches and BCP was found to have interaction with SIR-2.1, SKN-1 and DAF-16. The prediction was further validated in vivo using mutants and transgenic strains unraveling underlying genetic mechanism. It was observed that BCP increased lifespan of mev-1 and daf-16 but failed to augment lifespan in eat-2, sir-2.1 and skn-1 mutants. Relative quantification of mRNA demonstrated that several genes regulating oxidative stress, xenobiotic detoxification and longevity were modulated by BCP treatment. The study unravels the involvement of multiple signaling pathways in BCP mediated lifespan extension.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Longevidade/efeitos dos fármacos , Extratos Vegetais/administração & dosagem , Sesquiterpenos/administração & dosagem , Estresse Fisiológico/efeitos dos fármacos , Animais , Tamanho Corporal/efeitos dos fármacos , Caenorhabditis elegans , Proteínas de Caenorhabditis elegans/metabolismo , Proteínas de Ligação a DNA/metabolismo , Comportamento Alimentar/efeitos dos fármacos , Lipofuscina/metabolismo , Simulação de Acoplamento Molecular , Fitoterapia , Sesquiterpenos Policíclicos , Espécies Reativas de Oxigênio/metabolismo , Reprodução/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Fatores de Transcrição/metabolismo
20.
Int J Hyg Environ Health ; 217(4-5): 567-85, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24332576

RESUMO

This study was conducted to: (a) investigate the antagonistic interaction between selenium (Se) and mercury (Hg) in mothers and their newborns, (b) delineate the role of oxidative mechanisms induced by Hg exposure and (c) examine the protective effect of Se on Hg-induced oxidative stress and birth outcomes. Levels of Hg and Se were measured in umbilical cord blood and the placentas of 250 healthy mothers who participated in a study between 2006 and 2006 assessing prenatal exposure various pollutants. Levels of malondialdehyde (MDA) in cord and maternal blood and of 8-hydroxy-2-deoxyguanosine in urine were measured for assessing oxidative stress. Tail moment (TM) in the comet assay, as a biomarker of DNA damage was measured in samples of cord and maternal blood. The mean Se levels in umbilical cord blood (67.618±12.897µg/l) were lower than those reported in many countries, but none of the newborns had Se levels <20µg/l (the threshold limit of Keshan disease). More than 80% of the newborns, though, had Se levels below the 80µg/l needed for maximum glutathione peroxidase activity. Even though 18.6% of the newborns had levels of Hg ≥5.8µg/l (the reference dose of the Environmental Protection Agency), no relationship was observed with the biomarkers of oxidative stress. The mean placental Hg levels (0.056±0.075µg/g dry wt.) were higher than those reported for newborns with abnormal fetal development. Our study also documented significant placental transfer of Hg and Se to the fetus. The Hg/Se molar ratio in both cord blood and placental tissue was well below 1. The average amount of Se in both matrices was approximately 50-fold in molar excess over Hg. The molar excess of Se in the umbilical cord (0.843µmol/l), however, was lower than in placental tissues (13.098µmol/kg dry wt.). In further support of the relationships of Hg and Se on oxidative stress, we observed significantly lower levels of maternal MDA associated with Se levels in both cord blood and placental tissues and significantly higher TM levels associated with placental Hg in both newborns and their mothers. In contrast, Se/Hg molar ratios in placental tissues were positively associated with MDA and negatively with TM. The disproportion between Hg and Se might be influenced by the length of Hg exposure that in turn might affect Se bioavailability. Each birth anthropometric outcome was modeled as a function of Hg, Se and their interactions. After an adjustment for confounding variables, Hg in cord blood had a significantly positive rather than the expected negative association with crown-heel length. Placental Hg was associated with reduced birth height. Both associations were independent of prematurity. The status of Se in newborns was positively associated with crown-heel length and placental weight, with and without preterm births, and with birth weight, but only without preterm births. In contrast, a lower cephalization index was correlated with Se levels in cord blood, which may be an indicator of a detrimental effect on health. Our study, however, revealed associations between significantly lower levels of placental Se and several birth anthropometric measures (head circumference, birth weight and birth height) but the significance disappeared after excluding preterm births. Regression analyses generally indicated either significant or marginally significant Hg-Se antagonistic interactions that may have moderated the toxic effect of Hg on head circumference and birth weight. This finding may be due to chance or residual confounding and so may not be clinically relevant, but it may also suggest that Hg, Se and Hg-Se interactions are important factors for understanding Hg-induced adverse birth outcomes. Additional research will be necessary to evaluate the biological impact of combined metals in the assessment of fetal growth and development.


Assuntos
Sangue Fetal/química , Exposição Materna , Mercúrio/sangue , Estresse Oxidativo , Selênio/sangue , Adulto , Biomarcadores/sangue , Tamanho Corporal/efeitos dos fármacos , Ensaio Cometa , Feminino , Humanos , Masculino , Placenta/metabolismo , Gravidez , Resultado da Gravidez , Arábia Saudita
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA